Acute effects of nasal continuous positive airway pressure on 24-hour blood pressure and catecholamines in patients with obstructive sleep apnea

Internal Medicine

Volumn 37, Issue 12, 1998, Pages 1009-1013

  Minemura, Hiroshi ^a   Akashiba, Tsuneto ^a   Yamamoto, Hitoshi ^a   Akahoshi, Toshiki ^a   Kosaka, Naoko ^a   Horie, Takashi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Daytime blood pressure; Nighttime blood pressure; Plasma catecholamine; Urinary catecholamine

Indexed keywords

BIOLOGICAL MARKER; CATECHOLAMINE;

ARTICLE; BLOOD; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; COMPARATIVE STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; SLEEP APNEA SYNDROME; TREATMENT OUTCOME; URINE;

BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CATECHOLAMINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCADIAN RHYTHM; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; POSITIVE-PRESSURE RESPIRATION; SLEEP APNEA SYNDROMES; TREATMENT OUTCOME;

EID: 0032241389     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.37.1009     Document Type: Article

References (24)

1. Stradling JR. Sleep apnoea and hypertension. Thorax 44:984-989, 1989.
2. Hoffstein V, Chan CK, Slutsky AS. Sleep apnea and systemic hypertension: acausal association. Review. Am J Med 91: 190-196, 1991.
3. Levinson PD, Millman RP. Causes and consequences of blood pressure alterations in obstructive sleep apnea. Arch Intern Med 151: 455-462, 1991.
4. Carlson JT, Hedner JA, Ejnell H, et al. High prevalence of hypertension in sleep apnea patients independent of obesity. Am J Respir Crit Care Med 150: 72-77, 1994.
5. Fletcher EC. The relationship between systemic hypertension and obstructive sleep apnea: facts and theory. Am J Med 98: 118-128, 1995.
6. Motta J, Guilleminault C, Schroeder JS, Dement WC. Tracheostomy and hemodynamic changes in sleep-inducing apnea. Ann Intern Med 89: 454-458, 1978.
7. Lund-Johansen P, White W. Central hemodynamics and 24 hour blood pressure in obstructive sleep apnea syndrome: effects of corrective surgery. Am J Med 88: 678, 1990.
8. Wilcox I, Grunstein RR, Hedner JA, et al. Effects of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea. Sleep 16: 539-544, 1993.
9. Suzuki M, Otsuka K, Guilleminault C. Long-term nasal positive airway pressure administration can normalize hypertension in obstructive sleep apnea patients. Sleep 16: 545-549, 1993.
10. Akashiba T, Kurashina K, Minemura H, et al. Daytime hypertension and the effects of short-term nasal continuous positive airway pressure treatment in obstructive sleep apnea syndrome. Internal Med 34: 528-532, 1995.
11. Hedner JA, Wilcox I, Laks L, Grunstein RR, Sullivan CE. A specific and potent pressor effect of hypoxia in patients with sleep apnea. Am Rev Respir Dis 146: 1240-1245, 1992.
12. Ringler J, Basner RC, Shannon R, et al. Hypoxemia alone does not explain blood pressure elevations after obstructive apneas. J Appl Physiol 69: 2143-2148, 1990.
13. Hedner J, Ejnell H, Seligren J, Hedner T, Wallin G. Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? J Hypertens Suppl 6: S529-S531, 1988.
14. Fletcher EC, Miller J, Schaaf JW, Fletcher JG. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep 10: 35-44, 1987.
15. Baruzzi A, Riva R, Cirignotta F, Xucconi M, Cappelli M, Lugaresi E. Atrial natriuretic peptide and calecholamines in obstructive sleep apnea syndrome. Sleep 14: 83-86, 1991.
16. Marrone O, Riccobono L, Salvaggio A, Mirabella A, Bonanno A, Bonsignore MR. Catecholamines and blood pressure in obstructive sleep apnea syndrome. Chest 103: 722-727, 1993.
17. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques on scoring system for sleep apnea for sleep stage of human subjects. Bethesda: UCLA Brain Information Service, 1968.
18. Jeon HK, Nohta H, Nagaoka H, et al. Simultaneous determination of catecholamine-related compounds by high performance liquid chromatography with postcolumn chemical oxidation followed by a fluorescence reaction. Anal Sci 7: 257-262, 1991.
19. Waravdekar NV, Sinoway LI, Zwillich CW, Leuenberger E. Influence of treatment on muscle sympathetic nerve activity in sleep apnea. Am J Respir Crit Care Med 153: 1333-1338, 1996.
20. Krieger J, Schmidt M, Sforza E, et al. Urinary excretion of guanosine 3′:5′-cyclic monophosphate during sleep in obstructive sleep apnoea patients with and without nasal continuous positive airway pressure treatment. Clin Sci 76: 31-37, 1989.
21. Ehlenz K, Kohler U, Mayer J. et al. Plasma levels of catecholamines and cardiovascular parameters during sleep in patients with sleep apnea syndrome, in: Sleep Related Disorders and Internal Diseases, Peter JH, Podszus T, von Wiehert P, Eds. Springer-Verlag, Berlin, 1987: 321-325.
22. Eisenberg E, Zimlichman R, Lavie P. Plasma norepinephrine levels in patients with sleep apnea syndrome. N Engl J Med 322: 932-933, 1990 (letter).
23. Jennum P, Wildschiodtz, G, Christensen NJ, Schwanz T. Blood pressure, catecholamines, and pancreatic polypeptide in obstructive sleep apnea with and without nasal continuous positive airway pressure (nCPAP) treatment. Am J Hypertens 2: 847-852, 1989.
24. Rodenstein DO, D'Odemont JP, Pieters T, Aubert-Tulkens G. Diurnal and nocturnal diuresis and natriuresis in obstructive sleep apnea: Effects of nasal continuous positive airway pressure therapy. Am Rev Respir Dis 145: 1367-1371, 1992 (see comments).